Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 166 participants.

Also called NCT04434586

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 166 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04434586
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04434586. Randomized; single masking; primary purpose treatment. Start 2020-06-16 (actual); primary completion 2026-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions
Acronym
TOCAF
Condition
Superficial Femoral Artery Stenosis
Condition
Claudication
Condition
Ischemic Leg
Intervention (Device)
femoropopliteal revascularization for TASC C or TASC D lesion
Lead sponsor
University Hospital, Lille (class: other)
Collaborator
Abbott (class: industry)

Record details

Record id
cardio:ct-nct04434586
Content hash
21c3a191338597a35845a518b05dd71c7870f68578125b4babc28c8572affeab